Drug Type Small molecule drug |
Synonyms R 1295, R1295 |
Target |
Action antagonists |
Mechanism α4β1 antagonists(Integrin alpha-4/beta-1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | Europe | - | |
Asthma | Phase 1 | - | - | |
Multiple Sclerosis | Phase 1 | Europe | - | |
Multiple Sclerosis | Phase 1 | - | - | |
Rheumatoid Arthritis | Phase 1 | Europe | - | |
Rheumatoid Arthritis | Phase 1 | - | - |